CCR4 is a molecule involved in cell trafficking of lymphocytes to the skin and is expressed on the surface of malignant T- cells, making it an appropriate therapeutic target for CTCL (20–22). The gene discussed is CCR4; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.